← Back to home

B-cell acute lymphoblastic leukemia, diffuse large B-cell lymphoma, follicular lymphoma

Clinical trials for B-cell acute lymphoblastic leukemia, diffuse large B-cell lymphoma, follicular lymphoma explained in plain language.

Never miss a new study

Get alerted when new B-cell acute lymphoblastic leukemia, diffuse large B-cell lymphoma, follicular lymphoma trials appear

Sign up with your email to follow new studies for B-cell acute lymphoblastic leukemia, diffuse large B-cell lymphoma, follicular lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

500 patients to be tracked for long-term safety of cancer cell therapy

Knowledge-focused Recruiting now

This study follows 500 people in South Korea who have received tisagenlecleucel, a CAR-T cell therapy, for certain blood cancers like acute lymphoblastic leukemia and lymphomas. Researchers will monitor side effects, risk of new cancers, and how well the treatment works over time…

Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA, DIFFUSE LARGE B-CELL LYMPHOMA, FOLLICULAR LYMPHOMA

Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused

Last updated Aug 01, 2026 00:00 UTC

B-cell acute lymphoblastic leukemia, diffuse large B-cell lymphoma, follicular lymphoma

Get alerted when new B-cell acute lymphoblastic leukemia, diffuse large B-cell lymphoma, follicular lymphoma trials appear

500 patients to be tracked for long-term safety of cancer cell therapy